Quantum Blue® Infliximab

Quantum Blue® Infliximab

BÜHLMANN Quantum Blue®Infliximab is for Research Use Only in the US.

BÜHLMANN Quantum Blue®Infliximab: Health Canada License: 98838

The BÜHLMANN Quantum Blue® Infliximab is the first rapid test to measure infliximab in serum samples. The test is designed for the selective measurement of infliximab by a sandwich immunoassay.

The Quantum Blue® Infliximab assay measures from 0.4 to 20 µg/ml, and the target concentrations lies well within the linear range of the test. Quantum Blue® Infliximab provides a quantitative result within 15 minutes of incubation time. Quantum Blue® Infliximab is unique, being the only test that can provide fast, reliable information for infliximab, and correlating well with the standard routine ELISAs for determination of infliximab levels.

Quantum Blue® Infliximab Product Information

<

Test Quantum Blue® Infliximab
Method Lateral Flow
Time to Result 15 min (approx.)
Sample Type Serum
Standard Range 0.4-20 µg/ml
Catalog Number see below

Downloads‡

Infliximab Flyer for US [EN]

Infliximab Flyer for Canada [EN]

Infliximab Flyer [FR] (coming soon)

TDM Pipeline Flyer [EN] (coming soon)

BÜHLMANN Quantum Blue®Infliximab – LF-TLIF25-U

BÜHLMANN Quantum Blue® Infliximab Assay – LF-TLIF25*
* Multilingual [EN, FR]

Product Highlights
Learn more about the analyte, the advantages of the assay, and other interesting information related to this product.
News and Events
Visit our News page to learn about upcoming events, the latest news about new products, studies and BÜHLMANN in general.
View Citations
Learn about new publications citing use of our products in a variety of studies, applications, and fields of research.
US and Canada
Visit our contact page to enter your requests for quotations or to submit an order inquiry.
Sign Up for BUHLMANN Updates!

Enter your email and stay on top of things,